Home LiteratureArticle Details
PMID: 10072388 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Control of cell cycle progression by c-Jun is p53 dependent.

Genes & development ·Vol. 13 ·No. 5 ·1999-03-01 ·Pages 607-19

Schreiber M, Kolbus A, Piu F, Szabowski A, Möhle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF

Abstract

The c-jun proto-oncogene encodes a component of the mitogen-inducible immediate-early transcription factor AP-1 and has been implicated as a positive regulator of cell proliferation and G1-to-S-phase progression. Here we report that fibroblasts derived from c-jun-/- mouse fetuses exhibit a severe proliferation defect and undergo a prolonged crisis before spontaneous immortalization. The cyclin D1- and cyclin E-dependent kinases (CDKs) and transcription factor E2F are poorly activated, resulting in inefficient G1-to-S-phase progression. Furthermore, the absence of c-Jun results in elevated expression of the tumor suppressor gene p53 and its target gene, the CDK inhibitor p21, whereas overexpression of c-Jun represses p53 and p21 expression and accelerates cell proliferation. Surprisingly, protein stabilization, the common mechanism of p53 regulation, is not involved in up-regulation of p53 in c-jun-/- fibroblasts. Rather, c-Jun regulates transcription of p53 negatively by direct binding to a variant AP-1 site in the p53 promoter. Importantly, deletion of p53 abrogates all defects of cells lacking c-Jun in cell cycle progression, proliferation, immortalization, and activation of G1 CDKs and E2F. These results demonstrate that an essential, rate-limiting function of c-Jun in fibroblast proliferation is negative regulation of p53 expression, and establish a mechanistic link between c-Jun-dependent mitogenic signaling and cell-cycle regulation.

MeSH Terms
3T3 Cells Animals Cell Cycle/physiology Cell Division Cyclin G Cyclin G1 Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinases/metabolism Cyclins/biosynthesis,metabolism Enzyme Activation Mice Promoter Regions, Genetic Proto-Oncogene Proteins c-jun/metabolism Tumor Suppressor Protein p53/biosynthesis
Chemicals
Ccng1 protein, mouse Cdkn1a protein, mouse Cyclin G Cyclin G1 Cyclin-Dependent Kinase Inhibitor p21 Cyclins Proto-Oncogene Proteins c-jun Tumor Suppressor Protein p53 Cyclin-Dependent Kinases
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Schreiber M
Research Institute of Molecular Pathology (IMP), A-1030 Vienna, Austria.
Kolbus A
Piu F
Szabowski A
Möhle-Steinlein U
Tian J
Karin M
Angel P
Wagner E F
References (64)
64 references, click to expand
  1. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.
    Cell. 1994 Feb 25;76(4):747-60 PMID: 8124713
  2. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):157-61 PMID: 1729683
  3. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.
    Nature. 1996 Mar 7;380(6569):75-9 PMID: 8598911
  4. Expression of FosB during mouse development: normal development of FosB knockout mice.
    Oncogene. 1996 May 16;12(10):2177-85 PMID: 8668344
  5. Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity.
    Oncogene. 1992 Dec;7(12):2371-80 PMID: 1281302
  6. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation.
    Mol Cell Biol. 1993 Feb;13(2):841-51 PMID: 8423806
  7. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos.
    Oncogene. 1995 Jan 5;10(1):79-86 PMID: 7824281
  8. The jun and fos protein families are both required for cell cycle progression in fibroblasts.
    Mol Cell Biol. 1991 Sep;11(9):4466-72 PMID: 1908553
  9. The regulation of AP-1 activity by mitogen-activated protein kinases.
    J Biol Chem. 1995 Jul 14;270(28):16483-6 PMID: 7622446
  10. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers.
    Genes Dev. 1993 Mar;7(3):479-90 PMID: 8383624
  11. Constitutive cJun expression induces partial macrophage differentiation in U-937 cells.
    Cell Growth Differ. 1994 Apr;5(4):439-46 PMID: 8043518
  12. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts.
    Mol Cell Biol. 1996 May;16(5):2402-7 PMID: 8628308
  13. Erythropoietin activation of AP1 (Fos/Jun).
    Exp Hematol. 1995 Jul;23(7):619-25 PMID: 7601253
  14. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression.
    Genes Dev. 1992 Apr;6(4):676-89 PMID: 1313772
  15. c-jun is essential for normal mouse development and hepatogenesis.
    Nature. 1993 Sep 9;365(6442):179-81 PMID: 8371760
  16. The retinoblastoma protein and cell cycle control.
    Cell. 1995 May 5;81(3):323-30 PMID: 7736585
  17. Tumor spectrum analysis in p53-mutant mice.
    Curr Biol. 1994 Jan 1;4(1):1-7 PMID: 7922305
  18. D-type cyclin-dependent kinase activity in mammalian cells.
    Mol Cell Biol. 1994 Mar;14(3):2066-76 PMID: 8114738
  19. Induction of apoptosis by the transcription factor c-Jun.
    EMBO J. 1997 Apr 1;16(7):1695-709 PMID: 9130714
  20. Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle.
    Gene Expr. 1995;4(3):95-109 PMID: 7734951
  21. E2F and cell proliferation: a world turned upside down.
    Cell. 1996 May 17;85(4):457-9 PMID: 8653779
  22. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    Oncogene. 1995 Jul 20;11(2):365-76 PMID: 7624151
  23. Functional antagonism between c-Jun and MyoD proteins: a direct physical association.
    Cell. 1992 Feb 7;68(3):507-19 PMID: 1310896
  24. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  25. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  26. Inducible regulatory elements in the human cyclin D1 promoter.
    Oncogene. 1994 Jul;9(7):2105-7 PMID: 8208558
  27. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.
    Oncogene. 1997 Sep 4;15(10):1179-89 PMID: 9294611
  28. p53 in signaling checkpoint arrest or apoptosis.
    Curr Opin Genet Dev. 1996 Feb;6(1):12-8 PMID: 8791489
  29. Cdk inhibitors in development and cancer.
    Curr Opin Genet Dev. 1996 Feb;6(1):56-64 PMID: 8791491
  30. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis.
    Trends Cell Biol. 1996 Oct;6(10):388-92 PMID: 15157521
  31. Structural organization and chromosomal localization of the mouse collagenase type I gene.
    Biochem J. 1995 May 15;308 ( Pt 1):211-7 PMID: 7755567
  32. Protein-binding elements in the promoter region of the mouse p53 gene.
    Oncogene. 1990 Sep;5(9):1285-90 PMID: 2216454
  33. What is the restriction point?
    Curr Opin Cell Biol. 1995 Dec;7(6):835-42 PMID: 8608014
  34. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.
    J Cell Biol. 1963 May;17:299-313 PMID: 13985244
  35. Parallel signal processing among mammalian MAPKs.
    Trends Biochem Sci. 1995 Mar;20(3):117-22 PMID: 7709430
  36. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Genes Dev. 1995 May 15;9(10):1149-63 PMID: 7758941
  37. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.
    Cell. 1987 Jun 19;49(6):729-39 PMID: 3034432
  38. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.
    Mol Cell Biol. 1991 Mar;11(3):1344-52 PMID: 1996096
  39. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.
    Proc Natl Acad Sci U S A. 1995 May 23;92(11):4972-6 PMID: 7761434
  40. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Nature. 1991 Dec 12;354(6353):494-6 PMID: 1749429
  41. Drosophila Jun mediates Ras-dependent photoreceptor determination.
    Cell. 1994 Sep 23;78(6):973-86 PMID: 7923366
  42. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).
    Oncogene. 1995 Jul 20;11(2):211-9 PMID: 7624138
  43. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death.
    Neuron. 1995 May;14(5):927-39 PMID: 7748560
  44. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus.
    Curr Biol. 1995 Jul 1;5(7):747-57 PMID: 7583121
  45. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
    Genes Dev. 1995 Jun 1;9(11):1340-53 PMID: 7797074
  46. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle.
    Blood. 1992 Apr 15;79(8):2107-15 PMID: 1562737
  47. Cellular transformation and malignancy induced by ras require c-jun.
    Mol Cell Biol. 1996 Aug;16(8):4504-11 PMID: 8754851
  48. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture.
    Genes Dev. 1993 Jul;7(7B):1309-17 PMID: 8330736
  49. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.
    Nature. 1994 Oct 6;371(6497):534-7 PMID: 7935768
  50. Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells.
    Oncogene. 1995 Apr 6;10(7):1361-70 PMID: 7731687
  51. Cell cycle: routine role for Ras.
    Curr Biol. 1997 Apr 1;7(4):R258-60 PMID: 9162506
  52. Regulation of ES cell differentiation by functional and conformational modulation of p53.
    EMBO J. 1997 Oct 15;16(20):6217-29 PMID: 9321401
  53. Active repression of major histocompatibility complex class I genes in a human neuroblastoma cell line.
    J Biol Chem. 1996 Nov 29;271(48):30992-9 PMID: 8940088
  54. Cancer cell cycles.
    Science. 1996 Dec 6;274(5293):1672-7 PMID: 8939849
  55. Difference in transcriptional regulatory function between c-Fos and Fra-2.
    Nucleic Acids Res. 1991 Oct 25;19(20):5537-42 PMID: 1945831
  56. Cell-cycle control and its watchman.
    Nature. 1996 Jun 20;381(6584):643-4 PMID: 8649505
  57. Fos is an essential component of the mammalian UV response.
    EMBO J. 1995 Nov 1;14(21):5338-49 PMID: 7489723
  58. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
    Oncogene. 1993 Sep;8(9):2457-67 PMID: 8103211
  59. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.
    Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57 PMID: 1751545
  60. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Cell Growth Differ. 1995 May;6(5):579-86 PMID: 7544154
  61. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
    Genes Dev. 1995 Apr 15;9(8):935-44 PMID: 7774811
  62. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
    Mol Cell Biol. 1984 Sep;4(9):1689-94 PMID: 6092932
  63. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
    Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8493-7 PMID: 7667317
  64. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.
    Cancer Res. 1995 Dec 15;55(24):6244-51 PMID: 8521421
Article Info
Journal
Genes & development
Abbr.
Genes Dev
ISSN
0890-9369
Published
1999-03-01
Pages
607-19
Language
English
Region
United States
NLM ID
8711660
PMCID
PMC316508
Subset
IM
Grants
NIEHS NIH HHS · R01 ES006376 · United States
NIEHS NIH HHS · R37 ES004151 · United States
NIEHS NIH HHS · ES 04151 · United States
NIEHS NIH HHS · ES 06376 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]